Medical Research News

RSS

Iowa State study identifies potential new target for leukemia treatment

In leukemia's most aggressive forms, the blood cell factories in our bone marrow falter. Instead of dividing and multiplying at their usual prolific pace, generating hundreds of billions of new cells daily, some precursor cells stall out at an immature stage.

24 Jul 2026

MATILDA database reveals wide variation in dietary environmental impacts

Improving diets is one of the world's biggest public health and environmental challenges. More than 2.5 billion adults are now overweight or obese, 88% of countries with available data face a serious burden of two or more forms of malnutrition, and food systems account for between a quarter and a third of global greenhouse gas emissions.

24 Jul 2026

Inherited genetics can influence safety and success of CAR-T cell therapy

Chimeric antigen receptor (CAR)-T cell therapy, which reprograms an individual's immune cells to seek out and destroy certain cancer cells, has revolutionized treatment for blood cancers such as lymphoma.

24 Jul 2026

Study discovers new therapeutic targets for severe preeclampsia

Unusual behavior in the cells of mothers and babies with preeclampsia may provide new therapeutic targets for the condition, finds a new UCL-led study.

24 Jul 2026

Taiwan Biobank data reveals ongoing natural selection in living humans

For more than a century, scientists have sought to reconstruct human evolution using diverse lines of evidence, including fossils, genetic variation across populations, and ancient DNA.

24 Jul 2026

Cleveland Clinic study links gut microbe byproduct to heart arrhythmia

A Cleveland Clinic-led study shows a connection between elevated blood levels of TMAO (trimethylamine N-oxide) - a byproduct of gut bacteria digestion of nutrients found in red meat and other animal products - and a higher risk of atrial fibrillation.

24 Jul 2026

Two interconnected signaling pathways drive papillary thyroid carcinoma progression

A new research perspective was published in Volume 13 of Oncoscience on June 3, 2026, titled "The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma."

24 Jul 2026

NYU Abu Dhabi scientists discover new vulnerability in malaria parasite

Researchers at NYU Abu Dhabi have discovered that the malaria parasite relies on a specific type of fat to survive and multiply within the human host, uncovering a previously unknown vulnerability that could help guide future treatments.

24 Jul 2026

Individualized treatment speeds recovery for babies with opioid withdrawal

A major new study shows that individualized treatment for babies born with opioid withdrawal can speed recovery and reduce time spent in the hospital.

24 Jul 2026

New clinical framework maps pediatric Behçet’s spectrum disorders

Behçet's disease (BD) is a systemic vasculitis marked by recurrent oral and genital ulcers, but pediatric presentations are often partial or atypical, complicating diagnosis.

24 Jul 2026

West Virginia University study examines common triggers for anxious driving

West Virginia University researchers say driving anxiety, one of the most common phobias, is triggered by a variety of circumstances that can lead to panic attacks and an avoidance of the open road during the summer traveling season and at other times of the year.

24 Jul 2026

Microglia found to drive sleep loss in Alzheimer’s

There’s a small fire isolated in your kitchen. If you had the right tool, you might be able to put it out. But before you can, the sprinklers turn on and flood your entire house.

24 Jul 2026

Poor premature infant growth linked to lasting brain abnormalities

Research led by the University of Granada (UGR) paves the way for new intervention and monitoring strategies for this high-risk population.

24 Jul 2026

Spontaneous brain state fluctuations influence real-time memory formation

Most everyday moments are quickly forgotten, while others stay with us for a lifetime. How the brain determines which memories are retained and which are lost remains an open question.

24 Jul 2026

Cambridge scientists solve brain puzzle behind popular obesity drugs

Cambridge scientists have solved the mystery of why both stimulating and blocking a particular 'switch' in the brain can help people lose weight – findings which could help boost the effectiveness of obesity drugs.

24 Jul 2026

Researchers discover molecule to fight age-related muscle decline

Skeletal muscle is one of the first tissues to decline with age. This decline can lead to weakness, scarring, fat accumulation inside muscle, and the loss of fast-twitch muscle fibers that are important for quick and powerful movements.

24 Jul 2026

Oral drug candidate blocks transmission of measles-like disease in ferrets

A new oral antiviral drug candidate administered either before or after direct contact or airborne exposure to canine distemper virus, which causes measles-like disease in ferrets, blocks transmission of the virus and reduces clinical symptoms, according to a study published in the journal Nature Microbiology by researchers in the Center for Translational Antiviral Research (CTAR) at Georgia State University.

24 Jul 2026

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits

Newer GLP-1 receptor agonists, including semaglutide and tirzepatide, were associated with fewer alcohol-related ED visits or hospitalizations among adults with alcohol use disorder and type 2 diabetes or obesity.

24 Jul 2026

Siemens Healthineers launches an industry-leading menu for core lab capillary testing on Atellica analyzers with claims for 24 assays

Siemens Healthineers announced today that it has launched capillary testing on the Atellica CH, IM, and CI Analyzers after receiving CE-mark for 24 capillary blood testing claims, an advancement for capillary testing that offers clinical labs greater confidence in test results and higher throughput.

From Siemens Healthineers 24 Jul 2026

AI redesign helps enzymes evolve beyond natural limits

Researchers showed that AI-redesigned botulinum neurotoxin proteases provided more stable starting points for directed evolution, allowing enzymes to access beneficial mutations that were poorly tolerated in wild-type backgrounds. In BoNT/E models, the approach improved activity, evolvability, and specificity, including an ataxin-2-targeting variant with markedly reduced cleavage of the native SNAP25 substrate.

24 Jul 2026